Healthcare ❯ Pharmaceuticals ❯ Biotechnology

Drug Development

Clinical Trials Market Trends VYJUVEK AI in Healthcare EYLEA HD Psoriasis Treatments Bristol-Myers Squibb Metsera Immunology Drugs Acquisitions mRNA Technology Kiniksa Pharmaceuticals Alzheimer's Disease Patient Care Novo Nordisk Cancer Therapies Eli Lilly Market Analysis Eylea

Amgen's Cash Strength Versus Moderna's mRNA Pivot

The comparison shows whether steady, cash-generating commercial scale or a pipeline-driven recovery will best reward shareholders.

Lilly to Buy Merida Biosciences for Up to $2.875 Billion

Baron Health Care Fund Falls 6.97% in Q1, Repositions for Long-Term Growth

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Krystal Biotech Posts Strong Q4 as VYJUVEK Hits $107 Million, Pivots 2026 Growth to Ex‑U.S. Markets

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Eli Lilly Unveils $3 Billion Netherlands Plant for Oral GLP-1 Medicines as Stock Rises